Tirzepatide combines the actions of both GLP-1 and GIP receptor agonists, leading to potent effects on glucose control, weight loss, and potentially cardiovascular benefits
Significant weight loss may reduce your need for thyroid replacement hormone
In head-to-head clinical trial comparisons, semaglutide delivered 14.9% average weight loss at 68 weeks, while retatrutide achieved 24.2% weight loss at 48 weeks
Nature 518 , 197206 (2015)
Retatrutide is not yet FDA-approved, so we cannot prescribe it, but we can evaluate where you stand and start you on a proven option today
Chicory root fiber can provide textural benefits as well as various nutritional benefits for the health-conscious consumer